Prosecution Insights
Last updated: July 17, 2026
Application No. 19/349,565

SUTURE PASSER DEVICES, SYSTEMS, AND METHODS

Final Rejection §102
Filed
Oct 03, 2025
Priority
May 31, 2024 — provisional 63/654,779 +1 more
Examiner
DANG, PHONG SON H
Art Unit
3771
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Integrity Medical Services Inc.
OA Round
2 (Final)
78%
Grant Probability
Favorable
3-4
OA Rounds
2y 6m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 78% — above average
78%
Career Allowance Rate
540 granted / 690 resolved
+8.3% vs TC avg
Strong +24% interview lift
Without
With
+23.8%
Interview Lift
resolved cases with interview
Typical timeline
3y 3m
Avg Prosecution
17 currently pending
Career history
707
Total Applications
across all art units

Statute-Specific Performance

§101
0.7%
-39.3% vs TC avg
§103
70.8%
+30.8% vs TC avg
§102
21.5%
-18.5% vs TC avg
§112
2.7%
-37.3% vs TC avg
Black line = Tech Center average estimate • Based on career data from 690 resolved cases

Office Action

§102
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claim(s) 21-40 is/are rejected under 35 U.S.C. 102(a)(2) as being anticipated by US 11/723,651 to Simon. Simon teaches: Claim 21: A suture passer device comprising: a body (Fig. 1B reproduced with annotation below); a first jaw member (Fig. 1B reproduced with annotation below) extending from the body, the first jaw member configured for angular movement relative to the body (Fig. 1B); and a second jaw member (Fig. 1B reproduced with annotation below) extending from the body, the second jaw member comprising: a curved portion (Fig. 1B reproduced with annotation below) extending from the body and curved away from the first jaw member, a straight portion (Fig. 1B reproduced with annotation below) extending from a distal end of the curved portion, wherein the curved portion is configured to offset the straight portion with respect to the body (Figs. 1A-1B); a tissue penetrator (Fig. 1B reproduced with annotation below) extending at least partially through the second jaw member, the tissue penetrator configured to shift between a retracted position and an engaged position (Figs. 1A-1B); and a trigger configured to actuate the first jaw member and the tissue penetrator (Col. 14, ll. 55-63 and claim 1, grasping and firing mechanism controlled with a proximate located trigger-handle). Claim 22: The tissue penetrator is a needle (180, Fig. 1B). Claim 23: A distal end of the needle (126, Fig. 1B) is curved toward the second jaw member in the engaged position, and wherein a radius of curvature of the needle is sized and shaped to avoid cartilage of a knee when the needle is actuated in a tissue of the knee (Functional limitation, the needle of Simon having the similar structural limitations of a radius and the needle tip is curved toward the second jaw as claimed, therefore, it would have performed the same function as claimed). Claim 24: The second jaw member (Fig. 1B reproduced with annotation below) comprises a shoulder (141, Fig. 2B) configured to direct the tissue penetrator toward the first jaw member. Claim 25: A suture loader (115, Fig. 2B) in the second jaw member. Claim 26: The suture loader (115) comprises a notch in the straight portion of the second jaw member. Claim 27: The suture loader (115) comprises a slot perpendicular to the notch and aligned with the tissue penetrator (the notch of 115 is the space running proximal to distal of the second jaw member, the slot is the space running from the inner surface of the second jaw member radially into the jaw, therefore it is perpendicular to one another, as shown in Fig. 2B, the slot is aligned with the needle curvature). Claim 28: A notch in the tissue penetrator (124, Fig. 1B) and a suture retainer (suture capture member 134, Fig. 2B), wherein the notch of the tissue penetrator is configured to capture a suture loop (Fig. 1B), the tissue penetrator is configured to move the suture loop through the first jaw member (Fig. 1B), and the suture retainer is configured to selectively retain the suture loop (suture capture member 134 configured to capture/retain the loop). Claim 29: The suture loop (Fig. 1B), the suture loop configured to be released from the suture retainer by pulling on an end of the suture loop (Functional limitation, the loop in Simon is capable of doing such). Claim 30: The notch of the tissue penetrator (124 .Fig. 1B) is proximal to a distal end of the tissue penetrator (126, Fig. 1B). Claim 31: A suture passer device comprising: a body (Fig. 1B reproduced with annotation below); a first jaw member (Fig. 1B reproduced with annotation below) extending from the body, the first jaw member configured for angular movement relative to the body; and a second jaw member (Fig. 1B reproduced with annotation below) extending from the body, the second jaw member comprising: a first portion (Fig. 1B reproduced with annotation below) extending from the body and away from the first jaw member, a second portion (Fig. 1B reproduced with annotation below) extending from a distal end of the first portion, wherein the first portion is configured to offset the second portion with respect to the body; and a needle (Fig. 1B reproduced with annotation below) extending at least partially through the second jaw member, the needle configured to shift between a retracted position (Fig. 1A) and an engaged position (Fig. 1B); and a trigger (Fig. 1B reproduced with annotation below) configured to actuate the first jaw member and the tissue penetrator (Col. 14, ll. 55-63 and claim 1, grasping and firing mechanism controlled with a proximate located trigger-handle). Claim 32: The first portion of the second jaw member is curved (Fig. 1B reproduced with annotation below). Claim 33: A distal end of the needle (126, Fig. 1B) is curved toward the second jaw member in the engaged position, and wherein a radius of curvature of the needle is sized and shaped to avoid cartilage of a knee when the needle is actuated in a tissue of the knee (Functional limitation, the needle of Simon having the similar structural limitations of a radius and the needle tip is curved toward the second jaw as claimed, therefore, it would have performed the same function as claimed). Claim 34: The second jaw member (Fig. 1B reproduced with annotation below) comprises a shoulder (141, Fig. 2B) configured to direct the tissue penetrator toward the first jaw member. Claim 35: A suture loader (115, Fig. 2B) in the second jaw member. Claim 36: The suture loader (115) comprises a notch in the second portion of the second jaw member. Claim 37: The suture loader (115) comprises a slot perpendicular to the notch and aligned with the tissue penetrator (the notch of 115 is the space running proximal to distal of the second jaw member, the slot is the space running from the inner surface of the second jaw member radially into the jaw, therefore it is perpendicular to one another, as shown in Fig. 2B, the slot is aligned with the needle curvature). Claim 38: A notch in the tissue penetrator (124, Fig. 1B) and a suture retainer (suture capture member 134, Fig. 2B), wherein the notch of the tissue penetrator is configured to capture a suture loop (Fig. 1B), the tissue penetrator is configured to move the suture loop through the first jaw member (Fig. 1B), and the suture retainer is configured to selectively retain the suture loop (suture capture member 134 configured to capture/retain the loop). Claim 39: The suture loop (Fig. 1B), the suture loop configured to be released from the suture retainer by pulling on an end of the suture loop (Functional limitation, the loop in Simon is capable of doing such). Claim 40: The notch of the tissue penetrator (124 .Fig. 1B) is proximal to a distal end of the tissue penetrator (126, Fig. 1B). PNG media_image1.png 397 641 media_image1.png Greyscale Response to Arguments Applicant’s arguments with respect to claim(s) 21-40 have been considered but are moot because the new ground of rejection does not rely on any reference applied in the prior rejection of record for any teaching or matter specifically challenged in the argument. Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to PHONG SON DANG whose telephone number is (571)270-5809. The examiner can normally be reached Mon-Fri 8-5. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Elizabeth Houston can be reached at 571-272-7134. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /PHONG SON H DANG/Primary Examiner, Art Unit 3771
Read full office action

Prosecution Timeline

Oct 03, 2025
Application Filed
Dec 09, 2025
Non-Final Rejection (signed) — §102
Jan 20, 2026
Non-Final Rejection mailed — §102
Apr 20, 2026
Response Filed
May 08, 2026
Final Rejection mailed — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12678183
INVERTING THROMBECTOMY APPARATUSES AND METHODS
1y 11m to grant Granted Jul 14, 2026
Patent 12653520
SYNDESMOSIS FIXATION ASSEMBLY
1y 9m to grant Granted Jun 16, 2026
Patent 12642521
Methods of Tissue Repairs
3y 1m to grant Granted Jun 02, 2026
Patent 12635997
METHODS FOR THE USE OF TISSUE REPAIR AND SEALING DEVICES HAVING A DETACHABLE GRAFT AND CLASP ASSEMBLY
1y 9m to grant Granted May 26, 2026
Patent 12629171
LUBRICATED MEDICAL INSTRUMENT GUIDE
3y 8m to grant Granted May 19, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
78%
Grant Probability
99%
With Interview (+23.8%)
3y 3m (~2y 6m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 690 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month